Reuters Market Eye - Shares in Sun Pharmaceutical Industries Ltd(SUN.NS) rise 2 percent after Swedish drugmaker Meda AB(MEDAa.ST) said it was not involved in discussions with a potential buyer, contradicting reports that the two companies were in talks.
(To read full story, click here)
Two sources with direct knowledge of the situation had told Reuters on May 31 that Sun Pharmaceutical was in talks to buy Meda for $5 billion to $6 billion.
After those reports, investors had worried Sun would have to assume significant debt to finance the purchase.
(Reporting by Abhishek Vishnoi)
Trending On Reuters
The deaths of a number of witnesses in a massive fraud case surrounding cheating at college and government jobs has become the latest source of discomfort for the Bharatiya Janata Party (BJP), already on the defensive over influence trafficking allegations. Full Article
Insight - Car dashboards that act like smart phones raise safety issues Full Article